iSpecimen Inc
NASDAQ:ISPC
Intrinsic Value
iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. [ Read More ]
The intrinsic value of one ISPC stock under the Base Case scenario is 1.7194 USD. Compared to the current market price of 0.2951 USD, iSpecimen Inc is Undervalued by 83%.
Valuation Backtest
iSpecimen Inc
Run backtest to discover the historical profit from buying and selling ISPC stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
iSpecimen Inc
Current Assets | 8.2m |
Cash & Short-Term Investments | 5m |
Receivables | 2.9m |
Other Current Assets | 292.1k |
Non-Current Assets | 7.6m |
PP&E | 321.6k |
Intangibles | 7.2m |
Other Non-Current Assets | 27.6k |
Current Liabilities | 6m |
Accounts Payable | 3.9m |
Accrued Liabilities | 1.7m |
Other Current Liabilities | 415.8k |
Non-Current Liabilities | 29.1k |
Other Non-Current Liabilities | 29.1k |
Earnings Waterfall
iSpecimen Inc
Revenue
|
9.9m
USD
|
Cost of Revenue
|
-4.8m
USD
|
Gross Profit
|
5.1m
USD
|
Operating Expenses
|
-16.3m
USD
|
Operating Income
|
-11.2m
USD
|
Other Expenses
|
69.9k
USD
|
Net Income
|
-11.1m
USD
|
Free Cash Flow Analysis
iSpecimen Inc
ISPC Profitability Score
Profitability Due Diligence
iSpecimen Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
iSpecimen Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
ISPC Solvency Score
Solvency Due Diligence
iSpecimen Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Score
iSpecimen Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ISPC Price Targets Summary
iSpecimen Inc
Ownership
ISPC Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
ISPC Price
iSpecimen Inc
Average Annual Return | -34.89% |
Standard Deviation of Annual Returns | 67.34% |
Max Drawdown | -99% |
Market Capitalization | 2.7m USD |
Shares Outstanding | 9 087 470 |
Percentage of Shares Shorted | 6% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. The company is headquartered in Lexington, Massachusetts and currently employs 59 full-time employees. The company went IPO on 2021-06-17. The firm designed iSpecimen Marketplace platform to transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. The Company’s marketplace platform ingests de-identified healthcare data provided by healthcare supply partners. The iSpecimen Marketplace supports the supply chain management and bioprocurement process for specimens and associated data. The Company’s platform helps with administrating and reporting function for researchers, suppliers, and internal personnel, including user and compliance management. The firm serves to biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions.
Contact
IPO
Employees
Officers
The intrinsic value of one ISPC stock under the Base Case scenario is 1.7194 USD.
Compared to the current market price of 0.2951 USD, iSpecimen Inc is Undervalued by 83%.